BC3 Technologies, Inc.
Founded in 2018 in Baltimore, BC3 Technologies is a minority-owned enterprise dedicated to revolutionizing emergency medical response. The company focuses on addressing critical gaps in emergency medical care, particularly in the management of life-threatening arterial bleeding, through innovative hemostatic solutions. BC3 Technologies aims to save lives by providing efficient, effective, and accessible products for medical, military, and general consumer sectors.
Industries
N/A
Nr. of Employees
small (1-50)
BC3 Technologies, Inc.
3701-A Southwestern Blvd, Baltimore MD, 21229
Patents
Products
Aerosolized hemostatic wound spray
An aerosol-formulated chitosan-based wound spray designed to form a barrier and promote rapid hemostasis when applied to severe bleeding wounds.
Aerosolized hemostatic wound spray
An aerosol-formulated chitosan-based wound spray designed to form a barrier and promote rapid hemostasis when applied to severe bleeding wounds.
Services
Establishing regional distribution agreements and supply-chain support to commercialize aerosolized hemostatic products in international markets.
Provision of product demos and sample units for evaluation by clinicians, first responders, and purchasers.
Outreach and educational activities aimed at raising awareness and training stakeholders on rapid hemorrhage control and product use.
Establishing regional distribution agreements and supply-chain support to commercialize aerosolized hemostatic products in international markets.
Provision of product demos and sample units for evaluation by clinicians, first responders, and purchasers.
Outreach and educational activities aimed at raising awareness and training stakeholders on rapid hemorrhage control and product use.
Expertise Areas
- Aerosolized hemostatic product development
- Hemostatic formulation chemistry (chitosan-based)
- Medical device regulatory strategy and 510(k) submissions
- Preclinical and comparative efficacy testing
Key Technologies
- Aerosol delivery systems for topical therapeutics
- Chitosan-based hemostatic formulations
- Micron-scale particle engineering
- Timed-dose aerosol canister design